Dr. Kaushal has had an extensive career within investing, clinical medicine/academia and public policy. He works closely with GA's Healthcare sector to identify new investment opportunities and to provide strategic support for its portfolio companies.
Mohit is a lead investor/board member to numerous transformational companies including Humedica (acquired by Optum Health), Rxante (acquired by Millennium), Change Healthcare (acquired by Emdeon), Gravie, Elation Health, CitiusTech, Oak Street Health and Universal American (NYSE:UAM).
During his time in the Obama administration, he was a member of the White House Health IT task force; a cross agency team implementing the technology aspects of Health Reform. He also built and led the first dedicated health care team at the Federal Communications Commission, where his team initiated collaboration with the Food and Drug Administration for the regulatory streamlining of converged telecommunications, data analytics and medical devices leading to the release of the mobile medical applications guidance by the FDA.
In addition Dr. Kaushal is an Adjunct Professor at Stanford University with a joint position within the newly created Biomedical Data Science Department and the medical school.
Dr. Kaushal continues to be active within public policy and is a Scholar in Residence at the newly created Duke Margolis Center for Health Policy. He was previously a Visiting Scholar at the Brookings Institution. He has also been appointed to the FDASIA Workgroup of the Health IT Policy Committee and to the National Committee on Vital and Health Statistics, advising HHS on Data Access and Use.
Kaushal is an ER physician, holds an MBA from Stanford and an MD with distinction from Imperial College of Science, Technology and Medicine, London.